Metopirone

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 76336-455
  • Package NDC 76336-455-18
  • Application number NDA012911
  • SPL ID 47d0c075-05db-df45-e063-6294a90a4e12
  • SPL set ID 3a27d0ef-83a7-4e1c-9430-46a3326ee8d8
  • UNII ZS9KD92H6V
  • RxCUI 105450
  • RxCUI 199772

What the source publishes

Labeler
HRA Pharma Rare Diseases
Active ingredients
Metyrapone
Form
CAPSULE, GELATIN COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:76336-455_47d0c075-05db-df45-e063-6294a90a4e12
{
  "name": "Metopirone",
  "splId": "47d0c075-05db-df45-e063-6294a90a4e12",
  "labels": [
    {
      "setId": "3a27d0ef-83a7-4e1c-9430-46a3326ee8d8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a27d0ef-83a7-4e1c-9430-46a3326ee8d8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3a27d0ef-83a7-4e1c-9430-46a3326ee8d8"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "HRA Pharma Rare Diseases",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "18 CAPSULE, GELATIN COATED in 1 BOTTLE (76336-455-18)",
      "package_ndc": "76336-455-18",
      "identifierStatus": "well-formed",
      "marketing_start_date": "19620125"
    }
  ],
  "productId": "76336-455_47d0c075-05db-df45-e063-6294a90a4e12",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE, GELATIN COATED",
  "productNdc": "76336-455",
  "deaSchedule": null,
  "genericName": "Metyrapone",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "METYRAPONE",
      "strength": "250 mg/1"
    }
  ],
  "applicationNumber": "NDA012911",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "19620125",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175928",
      "N0000175921"
    ],
    "unii": [
      "ZS9KD92H6V"
    ],
    "rxcui": [
      "105450",
      "199772"
    ],
    "spl_set_id": [
      "3a27d0ef-83a7-4e1c-9430-46a3326ee8d8"
    ],
    "pharm_class_epc": [
      "Adrenal Steroid Synthesis Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Adrenal Steroid Synthesis Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "HRA Pharma Rare Diseases"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:76336-455_47d0c075-05db-df45-e063-6294a90a4e12"